A recent study found that, while about 80 percent of those viewing risk information for a fictitious allergy drug claimed to have read at least half or more of the warnings, an eye-tracking tool found they actually read little to none of the cautionary material on a product website. Of 29 people, eight did not read any of the side effect disclosure, some of which was supposedly unique to this medicine.